Will the Scottish Cancer Target for the year 2000 be met? The use of cancer registration and death records to predict future cancer incidence and mortality in Scotland

British Journal of Cancer

Volumn 73, Issue 9, 1996, Pages 1115-1121

  Sharp, L ^a,c   Black, R J ^a,b   Muir, C S ^a   Gemmell, I ^a   Finlayson, A R ^a   Harkness, E F ^a  

^a HEALTHCARE IMPROVEMENT SCOTLAND   (United Kingdom)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Cancer; Incidence; Mortality; Projections; Scotland; Targets

Indexed keywords

ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; DEMOGRAPHY; FEMALE; HUMAN; LARGE INTESTINE CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0029925558     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.214     Document Type: Article

References (42)

1. AITKEN REG, FARQUHAR W AND MOIR ATB. (1994). Cancer: advisory and co-ordinating bodies. Health Bull., 52, 47-50.
2. BARKER DJP. (1984). Time trends in cancer mortality in England and Wales. Br. Med. J., 288, 1325-1326.
3. BIRCH JM, MARSDEN HB, MORRIS JONES PH, PEARSON D AND BLAIR V. (1988). Improvements in survival from childhood cancer: results of a population based survey over 30 years. Br. Med. J., 296, 1372-1376.
4. BLACK RJ, SHARP L AND KENDRICK SW. (1993). Trends in Cancer Survival in Scotland, 1968-90. National Health Service in Scotland, Information & Statistics Division. ISD Publications: Edinburgh.
5. BLACK RJ, MACFARLANE G, MAISONNEUVE P AND BOYLE P. (1995). Cancer Incidence and Mortality in Scotland, 1960-1989. National Health Service in Scotland, Information & Statistics Division. ISD Publications: Edinburgh.
6. BOYLE P, KAYE SB AND ROBERTSON AG. (1987). Changes in testicular cancer in Scotland. Eur. J. Cancer Clin. Oncol., 23, 827-830.
7. BOYLE P, SOUKOP M, SCULLY C, ROBERTSON AG, BURNS MJ, GILLIS CR AND KAYE SB. (1988). Improving prognosis of Hodgkin's disease in Scotland. Eur. J. Cancer Clin. Oncol., 24, 229-234.
8. BOYLE P. (1989). Relative value of incidence and mortality data in cancer research. Recent Results Cancer Res., 114, 41-63.
9. BRESLOW NE. (1984). Extra-Poisson variation in log-linear models. Appl. Stat., 33, 38-44.
10. CLAYTON D AND SCHIEFLERS E. (1987). Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Star. Med., 6, 449-467.
11. EUROPEAN NETWORK OF CANCER REGISTRIES. (1995). European Cancer Incidence and Mortality Database (EUROCIM) User Manual, 2nd Edition. International Agency for Research on Cancer: Lyon.
12. GILLIS CR, HOLE DJ, STILL RM, DAVIS J AND KAYE SB. (1991). Medical audit, cancer registration and survival in ovarian cancer. Lancet, 337, 611-612.
13. HARDING MJ, PAUL J, GILLIS CR AND KAYE SB. (1993). Management of malignant teratoma: does referral to a specialist unit matter? Lancet, 341, 999-1002.
14. HAWKINS MM. (1989). Long term survival and cure after childhood cancer. Arch. Dis. Child., 64, 798-807.
15. HIGGINSON J, MUIR CS AND MUNOZ N. (1992). Human Cancer: Epidemiology and Environmental Causes. Cambridge University Press: Cambridge.
16. INFORMATION & STATISTICS DIVISION. (1994). Scottish Health Statistics. 1994. National Health Service in Scotland, Information & Statistics Division. ISD Publications: Edinburgh.
17. JUNOR EJ, HOLE DJ AND GILLIS CR. (1994). Management of ovarian cancer: referral to a multidisciplinary team matters. Br. J. Cancer, 70, 363-370.
18. KARJALAINEN S. (1990). Geographical variation in cancer patient survival in Finland: chance, confounding or effect of early treatment? J. Epidemiol. Comm. Health, 44, 210-214.
19. KARJALAINEN S AND PALVA I. (1989). Do treatment protocols improve end results? A study of survival of patients with multiple myeloma in Finland. Br. Med. J., 299, 1069-1072.
20. MCARDLE CS AND HOLE D. (1991). Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. Br. Med. J., 302, 1501-1505.
21. MACGREGOR JE, CAMPBELL MK, MANN EMF AND SWANSON KY. (1994). Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease. Br. Med. J., 308, 1407-1411.
22. MACKIE RM AND HOLE D. (1992). Audit of public education campaign to encourage earlier detection of malignant melanoma. Br. Med. J., 304, 1012-1015.
23. MILLER BA, RIES LG, HANKEY BF, KOSARY CL, HARRAS F, DEVESA SS AND EDWARDS BK. (1993). SEER Cancer Statistics Review 1973-1990. NIH Publication No. 93 2789: Bethesda.
24. MUIR CS. (1993). Cancer registry in cancer control: An overview with a Scottish dimension. Health Bull. 51, 208-229.
25. NATIONAL ALGORITHMS GROUP. (1985). Generalised Linear Interactive Modelling Program (GLIM) Version 3.77.
26. PETO J. (1989). Oral contraceptives and breast cancer: is the CASH study really negative? Lancet, 1, 522.
27. PONTEN J, ADAMIH AND SPAREN P. (1991). Trends in cancer survival and mortality rates. Med. Oncol. Tumour Pharm., 8, 147-153.
28. REGISTRAR GENERAL SCOTLAND. (1981-90). Annual Reports 1981-90. HMSO: Edinburgh.
29. REGISTRAR GENERAL SCOTLAND. (1993). Population Projections Scotland (1991 Based). HMSO: Edinburgh.
30. ROBERTSON C AND BOYLE P. (1986). Age, period and cohort models: the use of individual records. Stat. Med., 5, 527-536.
31. SCOTTISH HOME AND HEALTH DEPARTMENT. (1991). Health Education in Scotland: A National Policy Statement. HMSO: Edinburgh.
32. SCOTTISH HOME AND HEALTH DEPARTMENT. (1992). Scotland's Health: A Challenge to us All. HMSO: Edinburgh.
33. SCOTTISH HOME AND HEALTH DEPARTMENT. (1993). The Scottish Diet. Report of a Working Party to the Chief Medical Officer for Scotland. HMSO: Edinburgh.
34. SEGI M. (1960). Cancer Mortality for Selected Sites in 24 Countries (1950-1957). Tohoku University School of Medicine: Japan.
35. SHARP L, BLACK RJ, HARKNESS EF, FINLAYSON AR AND MUIR CS. (1993). Cancer Registration Statistics, Scotland 1981-1990. National Health Service in Scotland. Information & Statistics Division. ISD Publications: Edinburgh.
36. STILLER CA. (1994). Centralised treatment, entry to trials and survival. Br. J. Cancer., 70, 352-362.
37. STRONG JA. (1986). The Cervical Cytology Service in Scotland. Report by the Ad Hoc Group of the Histopathology Sub-committee of the Scientific Service Advisory Group chaired by Professor JA Strong. SHHD: Edinburgh.
38. TABAR L, FUGERBERG CJG, GAD A, BALDETORP L, HOLMBERG LH, GRÖNTOFT O, LJUNQVIST V, LUNDSTRÖM B. MÅNSON JL, EKLUND G, DAY NE AND PETTERSSON F. (1985). Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the breast cancer screening working group of the Swedish National Board of Health and Welfare. Lancet, 1, 829-832.
39. TOMATIS L. (1990). Cancer Causes, Occurrence and Control. International Agency for Research on Cancer Scientific Publications No. 100. IARC: Lyon.
40. UK NATIONAL CASE - CONTROL STUDY GROUP. (1989). Oral contraceptive use and breast cancer risk in young women. Lancet, 1, 973-982.
41. WARNER J, BEATTIE C AND SHARP L. (1993). Scottish Breast Screening Programme Report. National Health Service in Scotland, Information & Statistics Division. ISD Publications: Edinburgh.
42. WORLD HEALTH ORGANIZATION. (1990). Diet, Nutrition and the Prevention of Chronic Diseases. Technical Report Series 797. WHO: Geneva.